Macrophages at the Crossroads of Fibrosis and Immunosuppression

Low-dose emapalumab treatment in refractory macrophage activation syndrome secondary to adult onset still’s disease/systemic lupus erythematosus: insights from nine cases

• Jie Chen
• Liling Zhao
• Yanwei Lin
• Xinyue Lian
• Haiting Wang
• Liyang Gu
• Ran Wang
• Xiaodong Wang
• Shuang Ye
• Qiong Fu